Friday
SESSION XXIV: ADVANCES IN MEDICAL TREATMENT AND TREATMENT OF MEDICAL PROBLEMS: MEDICAL RISKS IN VASCULAR SURGERY AND WHAT CAN BE DONE TO REDUCE THEM (5-MINUTE TALKS)
SESSION XXIV SCHEDULE
10:43 AM - 10:48 AM Factors Predictive Of Mortality In Vascular Surgery Patients From A NSQIP Database: Does Functional Status And Obesity Matter?
  Presenters(s):Gregg S. Landis, MD  
10:49 AM - 10:58 AM Update On Value Of Statin Drugs In Vascular Patients And The Over 50 Population: Should All Our Patients Be On Them; Should All Of Us Be On Them? (9-Minute Talk)
  Presenters(s):Bruce A. Perler, MD, MBA  
10:59 AM - 11:04 AM Primary Prevention Of Atherosclerosis: Should Everyone >50 Be On Statins; Should They Be In The Drinking Water?
  Presenters(s):Allan D. Callow, MD, PhD  
11:05 AM - 11:10 AM How Should Statins Be Used Optimally: Dosage, Drug, Modulation Of Therapy According To Lipid Levels?
  Presenters(s):Michael R. Jaff, DO  
11:11 AM - 11:16 AM Value Of Continuous ECG Monitoring With An Implantable System (REVEAL XT) In Vascular Surgery Patients: What New Problems Can Be Detected And What Is The Prognostic Significance?
  Presenters(s):Don Poldermans, MD  
11:17 AM - 11:22 AM Medical Therapy And Advances In Critical Limb Ischemia: How Vascular Medicine And Cardiology Can Fundamentally Improve Outcomes
  Presenters(s):Alan T. Hirsch, MD  
11:23 AM - 11:28 AM How Should Beta Blockers Be Used In Vascular Surgery Patients In Light Of The POISE Trial Showing They Can Increase Stroke And Death Rates?
  Presenters(s):Don Poldermans, MD  
11:29 AM - 11:34 AM Update On The RHEOS Trial Of Carotid Sinus Stimulation For Poorly Controlled Hypertension: Is It A New Horizons For Vascular Surgeons?
  Presenters(s):Karl A. Illig, MD  
11:35 AM - 11:50 AM Panel Discussion
11:50 AM - 12:48 PM Lunch Served in the Exhibit Hall and in Other Designated Areas
END OF SESSION XXIV
previous next